Fabio Puglisi Selected Research

Fabio Puglisi Research Topics

Disease

93	Breast Neoplasms (Breast Cancer) 04/2022 - 01/2002
62	Neoplasms (Cancer) 04/2022 - 03/2002
11	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 07/2006
7	Triple Negative Breast Neoplasms 04/2022 - 01/2010
7	Neoplasm Metastasis (Metastasis) 02/2022 - 07/2013
6	Melanoma (Melanoma, Malignant) 07/2021 - 04/2013
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2004
5	Carcinoma (Carcinomatosis) 01/2016 - 03/2002
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 08/2004
3	Stomach Neoplasms (Stomach Cancer) 02/2022 - 12/2017
3	Nausea 02/2022 - 02/2013
3	Vomiting 02/2022 - 02/2013
3	Disease Progression 01/2021 - 10/2014
3	Inflammation (Inflammations) 11/2020 - 12/2018
3	Hypertension (High Blood Pressure) 09/2015 - 05/2011
3	Neutropenia 05/2015 - 10/2004
2	Circulating Neoplastic Cells 01/2021 - 07/2012
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 03/2002
2	Glioblastoma (Glioblastoma Multiforme) 12/2018 - 04/2018
2	Amenorrhea 02/2014 - 07/2009
2	Cardiotoxicity 01/2014 - 03/2008
2	Anemia 02/2009 - 09/2007
1	Adenocarcinoma 02/2022
1	Hyperglycemia 01/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021

Drug/Important Bio-Agent (IBA)

28	Hormones (Hormone)IBA 04/2022 - 01/2010
14	Trastuzumab (Herceptin)FDA Link 02/2022 - 11/2005
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
11	Biomarkers (Surrogate Marker)IBA 04/2021 - 07/2008
8	Tamoxifen FDA LinkGeneric 10/2021 - 02/2011
8	Bevacizumab (Avastin)FDA Link 05/2020 - 07/2006
7	Pharmaceutical PreparationsIBA 02/2022 - 11/2010
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 10/2004
7	Biological ProductsIBA 01/2019 - 06/2005
6	Messenger RNA (mRNA)IBA 02/2022 - 03/2002
6	Estrogen ReceptorsIBA 06/2021 - 07/2007
6	Phenobarbital (Luminal)FDA Link 06/2021 - 10/2015
5	human ERBB2 proteinIBA 02/2022 - 07/2010
5	Estrogens (Estrogen)FDA Link 06/2021 - 06/2005
5	exemestane (Aromasin)FDA Link 01/2021 - 07/2014
5	AnthracyclinesIBA 01/2020 - 06/2005
5	Capecitabine (Xeloda)FDA Link 01/2019 - 04/2009
4	Progesterone Receptors (Progesterone Receptor)IBA 06/2021 - 02/2011
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2021 - 01/2018
4	PlatinumIBA 05/2020 - 07/2019
4	Lapatinib (GW572016)FDA Link 01/2020 - 11/2011
4	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 04/2009
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2004
4	taxaneIBA 04/2018 - 09/2007
4	ErbB Receptors (EGF Receptor)IBA 02/2016 - 07/2010
4	Thymidine PhosphorylaseIBA 06/2013 - 09/2007
3	Antineoplastic Agents (Antineoplastics)IBA 11/2021 - 09/2007
3	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 10/2004
3	Circulating Tumor DNAIBA 05/2021 - 02/2019
3	Aromatase InhibitorsIBA 01/2021 - 07/2014
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 08/2019
3	Epirubicin (Ellence)FDA LinkGeneric 01/2020 - 07/2008
3	eribulin FDA Link 11/2019 - 05/2017
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2018 - 07/2007
3	pertuzumabIBA 04/2018 - 02/2016
3	Docetaxel (Taxotere)FDA Link 01/2017 - 07/2004
2	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2019
2	ribociclibIBA 11/2021 - 01/2018
2	palbociclibIBA 11/2021 - 01/2018
2	Letrozole (Femara)FDA LinkGeneric 11/2021 - 10/2021
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2020 - 05/2015
2	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2014 - 07/2006
2	liposomal doxorubicin (Doxil)FDA Link 04/2013 - 03/2008
2	1-dodecylpyridoxal (PLD)IBA 04/2013 - 03/2008
2	Taxoids (Taxanes)IBA 07/2009 - 09/2007
2	Epoetin Alfa (Epogen)FDA Link 02/2009 - 09/2007
2	Hemoglobins (Hemoglobin)IBA 02/2009 - 09/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2008 - 07/2004
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2022
1	CateninsIBA 02/2022
1	AntiemeticsIBA 02/2022
1	Immunoconjugates (Immunoconjugate)IBA 02/2022
1	trastuzumab deruxtecanIBA 02/2022
1	SteroidsIBA 02/2022
1	hydroxide ionIBA 11/2021
1	cobalt hydroxideIBA 11/2021
1	CobaltIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	lenvatinibIBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021

Therapy/Procedure

52	Therapeutics 02/2022 - 07/2004
37	Drug Therapy (Chemotherapy) 02/2022 - 10/2004
7	Adjuvant Chemotherapy 04/2022 - 07/2009
5	Immunotherapy 04/2022 - 01/2018
3	Radiotherapy 05/2021 - 05/2016
3	Neoadjuvant Therapy 07/2020 - 08/2004
3	Aftercare (After-Treatment) 10/2014 - 09/2007
2	Metastasectomy 01/2021 - 11/2020
1	Induction Chemotherapy 07/2021
1	Transjugular Intrahepatic Portasystemic Shunt 07/2021